Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T1rho: Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging

NCT03846232 is registered in ClinicalTrials.gov with Barcelonabeta Brain Research Center, Pasqual Maragall Foundation as lead sponsor.

NCT NCT03846232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03846232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T1rho: Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging
Lead sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Phase
Observational
Overall status
Completed
Start date
February 12, 2019
Completion date
December 31, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease